טוען...
Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
OBJECTIVE: Widespread implementation of cerebrospinal fluid (CSF) biomarkers of Alzheimer's disease (AD) in clinical settings requires improved accuracy for diagnosis of prodromal disease and for distinguishing AD from non‐AD dementias. Novel and promising CSF biomarkers include neurogranin, a...
שמור ב:
| הוצא לאור ב: | Ann Clin Transl Neurol |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley and Sons Inc.
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4704480/ https://ncbi.nlm.nih.gov/pubmed/26783546 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acn3.266 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|